8-K 1 enhance8k092308.htm ENHANCE SKIN PRODUCTS 8K, 09.23.08 enhance8k092308.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of Report (Date of Earliest Event Reported): September 23, 2008
 
Enhance Skin Products Inc.
(Exact Name of Registrant as Specified in Charter)
 
Nevada
  
000-52755
  
84-1724410
(State or Other Jurisdiction
of Incorporation)
 
(Commission File Number)
  
(IRS Employer
Identification No.)
 
695 South Colorado Boulevard, Suite 480, Denver, Colorado
  
80246
(Address of Principal Executive Offices)
  
(Zip Code)
 
Registrant’s Telephone Number, Including Area Code:   (416) 644-8318

 
________________________________________________________
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 
Item 8.01
Other events.

On September 23, 2008, we issued the attached press release that is incorporated herein by reference.
 
Item 9.01
Financial Statements and Exhibits.
 
(d) Exhibits
 
       
Exhibit No.
  
Description
  
99.1
  
Press Release of Enhance Skin Products Inc. dated September 23, 2008
  
 
 
 
 
 
 
 
 
 

 
 
- 2 -
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
 
Enhance Skin Products Inc.
     
 
By:
/s/ Dr. Samuel S. Asculai
   
Dr. Samuel S. Asculai
   
President/CEO, Principal Executive Officer
 
 
Dated: September 23, 2008
 
 
 
 
 
 
 
 
 
- 3 -